CKM, CKD Staging, and Kidney Failure Risk

Lecture collection · Visual teaching summary · October 3, 2026

Andrew Bland, MD, FACP, FAAP

Visual summary

Staging describes disease; prediction estimates a specified future outcome. State the population, endpoint, and action every time you use a score.

Two measurements locate CKD risk. See the diagram description and full text below.
· Download full-size illustration (PNG) · Download Markdown · Read text version ·

Illustration updated October 18, 2026. Educational schematic. Imaging and microscopy panels are illustrations, not patient studies. Full teaching text and sources follow.

Diagram description

Two measurements locate CKD risk. . Confirm chronicity and cause. G1 or G2 alone does not establish CKD without a marker of kidney damage. The infographic uses anatomical illustrations and integrated labels; the complete teaching text and evidence are below.

Text version

Name the question before the tool

CKM stage describes interconnected cardiovascular, kidney, and metabolic disease. CKD classification describes cause, GFR, and albuminuria. KFRE estimates kidney failure; PREVENT estimates cardiovascular events. None is a substitute for the others.

CKM stage tells a disease story

Stage 1 includes excess adiposity/prediabetes without other major CKM disease; stage 2 adds metabolic risks or CKD; stage 3 includes subclinical CVD or high-risk equivalents; stage 4 has clinical CVD with CKM factors. Use the published 2026 criteria for exact assignment.

Always collect eGFR AND UACR

Preserved filtration with substantial albuminuria is not low-risk kidney health. Confirm persistent abnormalities, assign G/A categories, and ask about diabetes, BP, smoking, lipids, adiposity, and established CVD. Missing UACR is missing information, not A1.

Use KFRE in its population

The four-variable equation uses age, sex, eGFR, and UACR and is used in CKD G3–G5. Do not apply it as a validated AKI or G1/G2 forecast. Explain the 2- or 5-year endpoint and that it is a population-based estimate.

Translate kidney risk into action

KDIGO suggests 5-year kidney-failure risk 3–5% to support nephrology referral, 2-year >10% for multidisciplinary care, and >40% for modality education/preparation. Symptoms, cause, eGFR, and trajectory can justify action regardless of the score.

Explain discordance with an example

A person may have established coronary disease and high cardiovascular risk but relatively low near-term kidney-failure risk. Continue secondary cardiovascular prevention while following CKD. A low KFRE never cancels the need for BP, lipid, smoking, or albuminuria-directed treatment.

Supporting evidence

Continue learning